制剂
| 产品编号 | 化学名称 | CAS号 | 可用性（库存情况） | 交货期 | 纯度 | 包装1 |
| M-A00001 | 7-Xylosyl-10-deacetyltaxol | 90332-63-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00002 | Ansamitocin P 3' | 66547-09-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00003 | Ansamitocin P-3 | 66584-72-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00004 | Mitomycin C | 50-07-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00005 | Auristatin E | 160800-57-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00006 | Auristatin F | 163768-50-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00007 | D8-MMAE | 2070009-72-0 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00008 | D8-MMAF hydrochloride | Limited or intermittent availability | 4 weeks | 98% | 10 mg | |
| M-A00009 | DC0-NH2 | 615538-51-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00010 | Dxd (Exatecan derivative) | 1599440-33-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00011 | (S)-(+)-Camptothecin | 7689-03-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00012 | Fmoc-Val-Ala-PAB-OH | 1394238-91-5 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00013 | MC-Val-Cit-PAB | 159857-80-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00014 | Mc-Val-Cit-PABC-PNP | 159857-81-5 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00015 | Fmoc-Val-Cit-PAB-PNP | 863971-53-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00016 | Fmoc-Val-Cit-PAB | 159858-22-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00018 | 6-Maleimidohexanoic acid N-hydroxysuccinimide ester | 55750-63-5 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00019 | SMCC | 64987-85-5 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00020 | Iberdomide (CC220) | 1323403-33-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00021 | Thalidomide-O-COOH | 1061605-21-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00022 | Pomalidomide (CC-4047) | 19171-19-8 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00023 | (S,R,S)-AHPC hydrochloride | 1448189-80-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00024 | Lenalidomide-Br | 2093387-36-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00025 | BC-1215 | 1507370-20-8 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00026 | Propargyl-PEG4-amine | 1013921-36-2 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00027 | Propargyl-PEG12-OH | 1036204-61-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00028 | Boc-11-aminoundecanoic acid | 10436-25-6 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00029 | Boc-NH-C4-acid | 27219-07-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00030 | 2-[2-(2-Aminoethoxy)ethoxy]acetic Acid | 134978-97-5 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00031 | PF-05231023 | 1037589-69-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00032 | PROTAC BET-binding moiety 2 | 916493-82-8 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00034 | (+)-JQ1 | 1268524-70-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00035 | ’PROTAC BRD4 Degrader-7 | 2413382-30-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00037 | Quizartinib | 950769-58-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00038 | Ibrutinib (PCI-32765) | 936563-96-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00039 | Tesirine (SG3249, MP-PEG8-VA-PABC-PBD DIMER) | 1595275-62-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00040 | Belzutifan (PT2977, MK-6482) | 1672668-24-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00041 | Tomivosertib | 1849590-01-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00042 | EAI045 | 1942114-09-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00043 | Tyrosine kinase-IN-1 | 705946-27-6 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00044 | PCI-33380 | 1022899-36-0 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00045 | NVP-BAW2881 | 861875-60-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00046 | BFH772 | 890128-81-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00047 | PD-161570 | 192705-80-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00048 | AEE788 | 497839-62-0 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00049 | Tyrphostin AG 528 | 133550-49-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00050 | DTP3 | 1809784-29-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00051 | FLLL32 | 1226895-15-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00052 | Axitinib | 319460-85-0 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00053 | Dihydrodiol-Ibrutinib | 1654820-87-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00054 | C 87 | 332420-90-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00055 | Ritlecitinib | 1792180-81-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00057 | SAR-20347 | 1450881-55-6 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00058 | (E)-AG 99 | 122520-85-8 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00059 | AG-494 | 133550-35-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00060 | NSC 228155 | 113104-25-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00061 | PD-1-IN-17 | 1673560-66-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00062 | RG14620 | 136831-49-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00063 | RG13022 | 136831-48-6 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00064 | PF-6274484 | 1035638-91-5 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00065 | (±)-Zanubrutinib | 1633350-06-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00066 | Zanubrutinib | 1691249-45-2 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00067 | Btk inhibitor 2 | 1558036-85-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00068 | BMS-935177 | 1231889-53-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00070 | TG 100572 (Hydrochloride) | 867331-64-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00071 | BMS-986142 | 1643368-58-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00072 | TG 100801 | 867331-82-6 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00073 | AZD-1480 | 935666-88-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00074 | hVEGF-IN-1 | 1637443-98-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00075 | BTK IN-1 | 1270014-40-8 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00076 | JAK3-IN-6 | 1443235-95-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00077 | Sorafenib | 284461-73-0 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00078 | BMS-1166 | 1818314-88-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00079 | Sorafenib (Tosylate) | 475207-59-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00080 | OSI-930 | 728033-96-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00081 | Hispidol | 5786-54-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00082 | FM-381 | 2226521-65-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00083 | Cediranib | 288383-20-0 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00084 | Dovitinib (lactate) | 692737-80-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00085 | Pazopanib | 444731-52-6 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00086 | CUDC-101 | 1012054-59-9 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00087 | Motesanib | 453562-69-1 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00088 | Motesanib (Diphosphate) | 857876-30-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00089 | RAF265 | 927880-90-8 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00090 | Sunitinib | 557795-19-4 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00091 | Vandetanib | 443913-73-3 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00092 | Afatinib | 850140-72-6 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00093 | Afatinib (dimaleate) | 850140-73-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00094 | SU5408 | 15966-93-5 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00095 | Gusacitinib | 1425381-60-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00096 | PD173074 | 219580-11-7 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00097 | Falnidamol | 196612-93-8 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
| M-A00098 | CL-387785 | 194423-06-8 | Limited or intermittent availability | 4 weeks | 98% | 10 mg |
Copyright © 2022 上海明圣康源药业有限公司 版权所有
地址：上海自由贸易试验区 沪ICP备2021036407号-1
